Literature DB >> 20574447

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.

Z Somlóová1, J Widimský, J Rosa, D Wichterle, B Strauch, O Petrák, T Zelinka, J Vlková, M Masek, J Dvoráková, R Holaj.   

Abstract

Metabolic syndrome (MS) is frequent clinical condition in patients with hypertension. Primary aldosteronism (PA) is a common form of secondary hypertension. This study was aimed at investigating the prevalence of the MS and its components in the two major forms of PA, in unilateral aldosterone-producing adenoma (APA) and bilateral aldosterone overproduction because of idiopathic hyperaldosteronism (IHA). The diagnosis of the particular form of PA was based on adrenal venous sampling and/or successful surgery confirmed by histopathological examination. We analyzed clinical and laboratory data from 100 patients with PA (50 patients with IHA and 50 patients with APA) and from 90 patients with essential hypertension (EH). Metabolic profiles of patients with bilateral form of PA (because of IHA) were similar to EH, but differed from those in patients with unilateral form of PA (APA). The prevalence of the MS (62% in IHA, 34% in APA and 56% in EH), the body mass index value (30±4 kg m(-2) in IHA, 27±5 kg m(-2) in APA and 29±5 kg m(-2) in EH) and triglycerides levels (1.9±0.9 mmol l(-1) in IHA,1.4±0.8 mmol l(-1) in APA and 2.01±1.39 mmol l(-1) in EH) were all significantly (P<0.05) higher in IHA compared with APA patients. Metabolic profile of patients with bilateral form of PA (because of IHA) is similar to EH in contrast to unilateral form of PA (APA).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574447     DOI: 10.1038/jhh.2010.65

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  19 in total

1.  Methodological flaws in the systematic review and meta-analysis on glucose metabolism disorders in patients with primary aldosteronism.

Authors:  O Steichen
Journal:  Ir J Med Sci       Date:  2015-02-15       Impact factor: 1.568

2.  Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.

Authors:  María Fernández-Argüeso; Eider Pascual-Corrales; Nuria Bengoa Rojano; Ana García Cano; Lucía Jiménez Mendiguchía; Marta Araujo-Castro
Journal:  Endocrine       Date:  2021-04-02       Impact factor: 3.633

3.  Biochemical and clinical characteristics of patients with primary aldosteronism: Single centre experience.

Authors:  Nataša Vujačić; Ivan Paunović; Aleksandar Diklić; Vladan Živaljević; Nikola Slijepčević; Nevena Kalezić; Mirjana Stojković; Miloš Stojanović; Biljana Beleslin; Miloš Žarković; Jasmina Ćirić
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

4.  Sex-specific Association of Primary Aldosteronism With Visceral Adiposity.

Authors:  Yu Hatano; Nagisa Sawayama; Hiroshi Miyashita; Tomoyuki Kurashina; Kenta Okada; Manabu Takahashi; Masatoshi Matsumoto; Satoshi Hoshide; Takahiro Sasaki; Shuichi Nagashima; Ken Ebihara; Harushi Mori; Kazuomi Kario; Shun Ishibashi
Journal:  J Endocr Soc       Date:  2022-06-25

Review 5.  The renin angiotensin aldosterone system and insulin resistance in humans.

Authors:  Patricia C Underwood; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

6.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

7.  Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.

Authors:  Shivraj Grewal; Andin Fosam; Liam Chalk; Arjun Deven; Mari Suzuki; Ricardo Rafael Correa; Jenny E Blau; Andrew Paul Demidowich; Constantine A Stratakis; Ranganath Muniyappa
Journal:  Endocrine       Date:  2021-01-18       Impact factor: 3.633

8.  Secondary metabolic syndrome: the frequency of factors which may underlie the parameters of metabolic syndrome.

Authors:  Aytekin Oguz; Banu Mesci; Gul Sagun; Damla Coksert Kilic; Demet Ozgil Yetkin; Arzu Akalin
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

9.  Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Authors:  Hiroki Kobayashi; Akira Haketa; Ueno Takahiro; Hiromasa Otsuka; Sho Tanaka; Yoshinari Hatanaka; Yukihiro Ikeda; Masanori Abe; Noboru Fukuda; Masayoshi Soma
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

10.  Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.

Authors:  Kuan-Ming Chen; Bo-Ching Lee; Po-Ting Chen; Kao-Lang Liu; Kuan-Heng Lin; Chin-Chen Chang; Tung-Hsin Wu; Jia-Sheng Hong; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.